Evidence mapPaperPMID 38984983Full record

ArticleFunction (Oxford, England)2024

Megalin Knockout Reduces SGLT2 Expression and Sensitizes to Western Diet-induced Kidney Injury.

Elynna B Youm, Katherine E Shipman, Wafaa N Albalawy, Amber M Vandevender, Ian J Sipula, Youssef Rbaibi, Allison E Marciszyn, Jared A Lashway, Emma E Brown, Corry B Bondi and 4 more

Abstract read
In one paragraph

Article in Function (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Megalin: A Sidekick or Nemesis of the Kidney?Journal of the American Society of Nephrology : JASN · 2025
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Elynna B YoumRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Katherine E ShipmanRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.ORCID 0000-0002-1152-8359
Wafaa N AlbalawyRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Amber M VandevenderDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Ian J SipulaDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Youssef RbaibiRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Allison E MarciszynRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Jared A LashwayDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Emma E BrownRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Corry B BondiRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Cary R Boyd-ShiwarskiRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Roderick J TanRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
Michael J JurczakDivision of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.ORCID 0000-0002-6335-6915
Ora A WeiszRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

Funding

VECTOR CORE FACILITYP30CA047904 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1988 to 2025
$32.4M
T32 Research Training in Diabetes and EndocrinologyT32DK007052 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 1986 to 2025
$1.6M
Pitt Integrated Clinical and Geroscience Research Training ProgramT32AG021885 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2003 to 2025
$983k
Resource Development CoreU54DK137329 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$953k
Renal Myofibroblast: Origins, Activation and FateR01DK064005 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2003 to 2005
$740k
Renal and Epithelial Biology Training ProgramT32DK061296 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2002 to 2005
$552k
Effect of Renal Nerves on Chronic Kidney DiseaseR01DK131991 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$478k
The Role of MCP-1 in Tubular-to-Glomerular Crosstalk in Proteinuric Kidney DiseaseK01DK124357 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$148k
Establishing new model systems to study low potassium induced kidney injuryR03DK138215 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · 2025 to 2025
$105k
NCI NIH HHS P30 CA047904NCRR NIH HHS S10 RR026480NIA NIH HHS T32 AG021885NIDDK NIH HHS K01 DK124357NIDDK NIH HHS K08 DK118211NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK064005NIDDK NIH HHS R01 DK125049NIDDK NIH HHS R01 DK131991NIDDK NIH HHS R03 DK138215NIDDK NIH HHS T32 DK007052NIDDK NIH HHS T32 DK061296NIDDK NIH HHS U54 DK137329NIH HHS R01 DK125049NIH HHS S10 OD028596
6 · The paper itself

Abstract

Megalin (Lrp2) is a multiligand receptor that drives endocytic flux in the kidney proximal tubule (PT) and is necessary for the recovery of albumin and other filtered proteins that escape the glomerular filtration barrier. Studies in our lab have shown that knockout (KO) of Lrp2 in opossum PT cells leads to a dramatic reduction in sodium-glucose co-transporter 2 (SGLT2) transcript and protein levels, as well as differential expression of genes involved in mitochondrial and metabolic function. SGLT2 transcript levels are reduced more modestly in Lrp2 KO mice. Here, we investigated the effects of Lrp2 KO on kidney function and health in mice fed regular chow (RC) or a Western-style diet (WD) high in fat and refined sugar. Despite a modest reduction in SGLT2 expression, Lrp2 KO mice on either diet showed increased glucose tolerance compared to control mice. Moreover, Lrp2 KO mice were protected against WD-induced fat gain. Surprisingly, renal function in male Lrp2 KO mice on WD was compromised, and the mice exhibited significant kidney injury compared with control mice on WD. Female Lrp2 KO mice were less susceptible to WD-induced kidney injury than male Lrp2 KO. Together, our findings reveal both positive and negative contributions of megalin expression to metabolic health, and highlight a megalin-mediated sex-dependent response to injury following WD.

Indexed as

Diet, WesternLow Density Lipoprotein Receptor-Related Protein-2Mice, KnockoutSodium-Glucose Transporter 2AnimalsFemaleKidneyKidney Tubules, ProximalMaleMiceMice, Inbred C57BLLow Density Lipoprotein Receptor-Related Protein-2Lrp2 protein, mouseSlc5a2 protein, mouseSodium-Glucose Transporter 2glucose tolerancemetabolismproximal tubule

Identifiers

PMID38984983
PMCPMC11237895

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.